Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares
Clinical trial NCT00610363 · COMPLETED
Trial details
- NCT number
- NCT00610363
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-10-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.